1. Home
  2. ANGH vs XLO Comparison

ANGH vs XLO Comparison

Compare ANGH & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anghami Inc.

ANGH

Anghami Inc.

HOLD

Current Price

$4.96

Market Cap

51.6M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.00

Market Cap

49.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANGH
XLO
Founded
2012
2016
Country
United Arab Emirates
United States
Employees
191
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.6M
49.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ANGH
XLO
Price
$4.96
$9.00
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
23.2K
27.3K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.25
$0.46
52 Week High
$7.89
$9.25

Technical Indicators

Market Signals
Indicator
ANGH
XLO
Relative Strength Index (RSI) 61.59 66.03
Support Level $2.61 $7.47
Resistance Level $5.27 N/A
Average True Range (ATR) 0.78 0.50
MACD 0.10 0.09
Stochastic Oscillator 41.90 83.19

Price Performance

Historical Comparison
ANGH
XLO

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. The Group's three reportable segments: Revenue from subscriptions, Revenue from advertisement, and Revenue from live events. It generates the majority of its revenue from subscriptions segment, which is comes from subscription fees. The advertisement revenue segment generated through the sale of advertising across the Group's content. Revenues from live events are generated from the sale of tickets, food and beverage & sponsorship. It derives maximum revenue from KSA.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: